`
`First Named Inventor: Hidekazu MASAKI
`
`Confirmation No.: 2363
`
`Applicant: (1) EPSILON MOLECULAR
`ENGINEERING,INC. and (2) THE KITASATO
`INSTITUTEand (3) KAO CORPORATION
`
`Art Unit: to be assigned
`
`Application No.: 18/029,185
`
`Examiner: fo be assigned
`
`§ 371(c) Date: March 29, 2023
`
`Atty. Docket: 2537.2210006/MAC
`
`Title: SARS-COV-2-BINDING PEPTIDE
`
`Request for Corrected Official Filing Receipt
`
`Commissionerfor Patents
`PO Box 1450
`Alexandria, VA 22313-1450
`
`Commissioner:
`
`Mail Stop Missing Parts
`
`Applicant hereby requests that a corrected Official Filing Receipt be issued and sent to the
`
`undersigned representative. Specifically, the following corrections to the Official Filing Receipt are
`
`requested:
`
`In the Foreign Applications section, delete "ANDORRA"and replace with --JAPAN--.
`
`In support of the above request, a marked-up copy of the instant Official Filing Receiptis
`
`enclosed to show the corrections. Support can be found in the Application Data Sheetfiled March
`
`29, 2023. It is requested that a corrected Official Filing Receipt be issued, and sent to the
`
`undersignedat the earliest possible time.
`
`Atty. Dkt. No. 2537.2210006
`
`
`
`Hidekazu MASAKI
`Application No. 18/029,185
`
`Respectfully submitted,
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`/ Michele A. Cimbala /
`
`Michele A. Cimbala
`Attorney for Applicant
`Registration No. 33,851
`
`Date: August 11, 2023
`1101 K Street, NW, 10" Floor
`Washington, D.C. 20005
`Main: 202-371-2600
`Direct: 202-772-8544
`
`20745008. 1
`
`Atty. Dkt. No. 2537.2210006
`
`